Trial Profile
Vancomycin Versus Placebo in Persistently Febrile Granulocytopenic Patients Given Piperacillin/Tazobactam.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Jul 2015
Price :
$35
*
At a glance
- Drugs Piperacillin/tazobactam (Primary) ; Vancomycin
- Indications Bacterial infections; Febrile neutropenia
- Focus Therapeutic Use
- 05 Aug 2008 New trial record.